This company listing is no longer active
Liminal BioSciences Balance Sheet Health
Financial Health criteria checks 5/6
Liminal BioSciences has a total shareholder equity of CA$36.2M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$50.5M and CA$14.3M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$37.14m |
Equity | CA$36.21m |
Total liabilities | CA$14.25m |
Total assets | CA$50.46m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PJ2's short term assets (CA$41.3M) exceed its short term liabilities (CA$10.1M).
Long Term Liabilities: PJ2's short term assets (CA$41.3M) exceed its long term liabilities (CA$4.1M).
Debt to Equity History and Analysis
Debt Level: PJ2 is debt free.
Reducing Debt: PJ2 has no debt compared to 5 years ago when its debt to equity ratio was 60.7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PJ2 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PJ2 has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.4% each year.